SYDNEY, Australia, June 06, 2024 (GLOBE NEWSWIRE) -- EnGeneIC, a clinical-stage biopharmaceutical company pioneering the development of a First-in-Class targeted nanocell for cancer therapy has today announced strategic partnerships with ...
Read MoreAUCKLAND, New Zealand, June 06, 2024 (GLOBE NEWSWIRE) -- The shortest day of the year is fast approaching, and as we crank up our heaters, Build & Renovate Magazine's latest edition is here to help you stay warm and cosy this winter. ...
Read MoreBARCELONA, Spain and SAN FRANCISCO, June 05, 2024 (GLOBE NEWSWIRE) -- Mediktor , the leading digital healthcare company, has announced the acquisition of Sensely , a San Francisco-based, digital healthcare provider that pioneered an ...
Read MoreJune 4, 2024 New FDA-cleared AI-enabled applications include the industry’s first automated tool for segmental wall motion scoring of the heart to quickly and objectively identify disorders including coronary artery disease and cardio-oncology ...
Read MorePORTSMOUTH, N.H. , April 30, 2024 /PRNewswire/ -- Laborie Medical Technologies Corp. (Laborie), a leading diagnostic and therapeutic medical technology company, welcomed the inclusion of Optilume ® Urethral Drug-Coated Balloon (DCB) into ...
Read MoreTAIPEI , April 30, 2024 /PRNewswire/ -- Foresee Pharmaceuticals (TPEx: 6576), ("Foresee") today announced that the first subject has been dosed in its Phase 1 clinical trial of FP-020 in Australia . The Phase 1 clinical trial is a ...
Read MoreZimmerman Reed announces $7 million settlement for the U.S. and State of California in a first-of-its kind False Claims Act case involving a COVID-19 waiver program. MINNEAPOLIS, Minn. , April 29, 2024 /PRNewswire-PRWeb/ -- ...
Read MoreA national consortium based at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) was awarded $17 million by the U.S. Department of Defense for new research in traumatic brain injury and psychological ...
Read MoreSubscribe to our Free Newsletters!